Evaluation of the efficacy of nasal spray formulation containing tea tree oil in the treatment of seasonal allergic rhinitis
Phase 3
Recruiting
- Conditions
- Seasonal allergic rhinitis.Other seasonal allergic rhinitisJ30.2
- Registration Number
- IRCT20210718051920N2
- Lead Sponsor
- Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Seasonal allergic rhinitis confirmed by skin prick test
Exclusion Criteria
Structural disorders of the nose such as nasal polyps, nasal deviation and other structural disorders
Asthma
Chronic obstructive pulmonary disease (COPD)
Rhinosinusitis
Chronic diseases such as kidney failure, liver failure, hypertension, diabetes, ischemic heart disease, Malignancy, and systemic inflammatory diseases
Respiratory infections during the previous 8 weeks
Use of oral corticosteroids during the previous week
Pregnancy
Lactation
Patients who are receiving immunotherapy or have a history of immunotherapy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The severity of the symptoms of seasonal allergic rhinitis. Timepoint: At the initiation of the study and every day. Method of measurement: Total nasal symptom score (TNSS).
- Secondary Outcome Measures
Name Time Method Control of the symptoms of seasonal allergic rhinitis. Timepoint: At the beginning of the study and at the end of the first and second weeks of the study. Method of measurement: Rhinitis Control Assessment Test questionnaire.;Quality of life. Timepoint: At the beginning of the study and at the end of the first and second weeks of the study. Method of measurement: Mini rhinoconjunctivitis quality of life questionnaire (Mini RQLQ).